Daratumumab + bortezomib/lenalidomide/dexamethasone in transplant ineligible/ transplant deferred newly diagnosed MM: Phase 3 CEPHEUS results Meeting Abstract


Authors: Basu, S.; Usmani, S.; Facon, T.; Hungria, V.; Bahlis, N.; Venner, C.; Braunstein, M.; Rowe, M.; Carson, R.; Zweegman, S.
Abstract Title: Daratumumab + bortezomib/lenalidomide/dexamethasone in transplant ineligible/ transplant deferred newly diagnosed MM: Phase 3 CEPHEUS results
Meeting Title: 65th Annual Scientific Meeting of the British Society for Haematology (BSH25)
Journal Title: British Journal of Haematology
Volume: 206
Issue: Suppl. 1
Meeting Dates: 2025 Apr 27-29
Meeting Location: Glasgow, Scotland
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2025-04-01
Language: English
ACCESSION: WOS:001517858300139
PROVIDER: wos
DOI: 10.1111/bjh.20117
Notes: Meeting Abstract: PO20 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Saad Zafar Usmani
    345 Usmani
Related MSK Work